|
Index of reports
> Cases with Neuroleptic Malignant Syndrome ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include neuroleptic malignant syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Invega side effects in 49 year old male
Reported by a physician from Japan on 2012-05-24
Patient: 49 year old male
Reactions: Overdose, Neuroleptic Malignant Syndrome, Drug Prescribing Error, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-04-22
End date: 2011-05-05
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hirnamine; Phenobarbital TAB; Rhythmy; Bepotastine Besilate; Phenobarbital TAB; Nitrazepam; Hirnamine; Lexotan; Akineton; Clonazepam
Possible Invega side effects in 12 year old male
Reported by a physician from United States on 2012-05-24
Patient: 12 year old male
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Invega
Possible Invega side effects in 21 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-20
Patient: 21 year old male
Reactions: Neuroleptic Malignant Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Invega Sustenna
Indication: Product Used FOR Unknown Indication
End date: 2011-11-01
Strattera
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a physician from Japan on 2012-03-09
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Blood Creatine Phosphokinase Increased, Head Injury, Alanine Aminotransferase Increased, Chills, Incontinence, Aspartate Aminotransferase Increased, Bronchitis, Neuroleptic Malignant Syndrome, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Selbex
Administration route: Oral
Indication: Gastritis
Start date: 2010-07-23
End date: 2012-02-12
Haloperidol Decanoate
Start date: 2010-05-27
End date: 2011-12-05
Invega
Administration route: Oral
Indication: Irritability
Start date: 2011-08-23
End date: 2012-02-12
Haloperidol Decanoate
Indication: Schizophrenia
Start date: 2011-12-06
End date: 2012-02-07
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-08-23
End date: 2012-02-12
Other drugs received by patient: Akineton; Magmitt; Diazepam; Luvox; Rize; Luvox
Possible Invega side effects in male
Reported by a physician from Japan on 2012-03-05
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Head Injury, Bronchitis, Neuroleptic Malignant Syndrome, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Haloperidol Decanoate
Start date: 2010-05-27
End date: 2011-12-05
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-08-23
End date: 2012-02-12
Selbex
Administration route: Oral
Indication: Gastritis
Start date: 2010-07-23
End date: 2012-02-12
Haloperidol Decanoate
Indication: Schizophrenia
Start date: 2011-12-06
End date: 2012-02-07
Invega
Administration route: Oral
Indication: Irritability
Start date: 2011-08-23
End date: 2012-02-12
Other drugs received by patient: Luvox; Luvox; Diazepam; Rize; Akineton; Magmitt
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-09
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Electroencephalogram Abnormal, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-15
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Duloxetine Hydrochloride
Indication: Product Used FOR Unknown Indication
Zolpidem Tartrate
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-01
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Electroencephalogram Abnormal, Blood Creatine Phosphokinase Increased, Liver Function Test Abnormal, Neuroleptic Malignant Syndrome, Convulsion
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-11-15
Zolpidem Tartrate
Indication: Product Used FOR Unknown Indication
Duloxetine Hydrochloride
Indication: Product Used FOR Unknown Indication
Lithium Carbonate
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-22
Patient: male, weighing 65.8 kg (144.7 pounds)
Reactions: Rhabdomyolysis, Compartment Syndrome, Drug Administration Error, Neuroleptic Malignant Syndrome, LEG Amputation, Extremity Necrosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2008-07-01
End date: 2008-08-19
Invega
Administration route: Oral
Indication: Bipolar Disorder
Other drugs received by patient: Depakote; Zyrtec; Depakote; Lithium Carbonate; Catapres; Singulair; Depakote; Benadryl; Trazodone HCL
|
